Pajjiż: Stati Uniti
Lingwa: Ingliż
Sors: NLM (National Library of Medicine)
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)
Contract Pharmacy Services-PA
Docusate Sodium
Docusate Sodium 100 mg
ORAL
OTC DRUG
Stool softener - prevents/relieves dry hard stool - results usually occurs 1 to 3 days after the first dose
OTC monograph not final
DOCUSATE SODIUM- DOCUSATE SODIUM CAPSULE CONTRACT PHARMACY SERVICES-PA _Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they_ _comply with applicable regulations and policies. FDA has not evaluated whether this product complies._ ---------- DRUG FACTS ACTIVE INGREDIENT (IN EACH SOFTGEL) Docusate sodium 100 mg PURPOS E Stool softener US ES prevents/relieves dry hard stool results usually occurs 1 to 3 days after the first dose WARNINGS DO NOT USE when abdominal pain, nausea, or vomiting are present for more than one week unless directed by a doctor ASK A DOCTOR BEFORE USE IF YOU are taking mineral oil have noticed a sudden change in bowel habits that last over 2 weeks STOP USE AND ASK A DOCTOR IF you have no bowel movement after 3 days you have rectal bleeding These could be signs of a serious condition IF PREGNANT OR BREAST-FEEDING, ask a health professional before use. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away. DIRECTIONS do not exceed recommended dose adults and children over 12 take 1-2 softgels daily until first bowel movement; 1 softgel years daily thereafter children 6 to 12 years take 1 softgel daily children under 6 years consult a doctor OTHER INFORMATION TAMPER EVIDENT: DO NOT USE IF SAFETY SEAL UNDER CAP IS BROKEN OR MISSING store at room temperature 15 to 30 C (59 to 86 F) protect from moisture INACTIVE INGREDIENTS: D&C YELLOW # 10, FD&C RED # 40, GELATIN, GLYCERIN, INK WHITE, POLYETHYLENE GLYCOL, SORBITOL, PROPYLENE GLYCOL. QUES TIONS ? Adverse drug event call: (866) 562-2756 PRINCIPAL DISPLAY PANEL o o o o DOCUSATE SODIUM docusate sodium capsule PRODUCT INFORMATION PRODUCT T YPE HUMAN OTC DRUG ITE M CODE (SOURCE ) NDC:6 70 46 -140 (NDC:16 10 3-38 4) ROUTE OF ADMINISTRATION ORAL ACTIVE INGREDIENT/ACTIVE MOIETY INGREDIENT NAME BASIS OF STRENGTH STRE NG TH DO CUSATE SO DIUM (UNII: F0 5Q2T2JA0 ) (DOCUSATE - UNII:M7P2719 5AG) DOCUSATE SODIUM 10 0 mg INACTIVE INGREDIENTS INGREDIENT NAM Aqra d-dokument sħiħ